FreeIn the Archives “Less Radical” podcast: Resistance to change, a data scandal November 01, 2024Vol.50 No.41
In Brief ECOG-ACRIN, Caris collaborate on interrogating TAILORx breast cancer trial October 25, 2024Vol.50 No.40
Clinical Roundup Medicaid expansion may improve cancer care and survival for people with HR-negative, HER2-positive breast cancer October 25, 2024Vol.50 No.40
In Brief Flatiron Health surpasses 1,000 research publications using RWD from its de-identified patient database October 18, 2024Vol.50 No.39
FreeIn the Archives Less Radical podcast: The origins of modern surgery, radical mastectomy, and the first randomized trials in breast cancer October 11, 2024Vol.50 No.38
Clinical Roundup Breast cancer mortality continues three-decade decline, but steeper increases for women under 50 & AAPI women of all ages October 11, 2024Vol.50 No.38
Clinical Roundup AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution October 11, 2024Vol.50 No.38
Clinical Roundup Study finds common breast cancer treatments may speed aging process October 11, 2024Vol.50 No.38
Drugs & Targets FDA approves inavolisib + palbociclib + fulvestrant for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer October 11, 2024Vol.50 No.38
